This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Seoul National University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Hyeon-Seop Kim: Innovator in Chondrosarcoma Treatment
Introduction
Hyeon-Seop Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical research, particularly in the treatment of chondrosarcoma, a rare type of cancer that affects cartilage.
Latest Patents
Hyeon-Seop Kim holds a patent for the use of HIF-2α inhibitors for treating chondrosarcoma or preventing its recurrence and metastasis. The patent describes a method of treating chondrosarcoma by regulating HIF-2α, which can effectively suppress metastasis or recurrence during the development of this cancer, especially in cases of dedifferentiated chondrosarcoma.
Career Highlights
Hyeon-Seop Kim is affiliated with Seoul National University, where he conducts research and develops innovative treatments for cancer. His work has garnered attention for its potential to improve patient outcomes in chondrosarcoma treatment.
Collaborations
He collaborates with notable colleagues, including Jin-Hong Kim and Hyeonkyeong Kim, to advance research in this critical area of medicine.
Conclusion
Hyeon-Seop Kim's innovative approach to treating chondrosarcoma through HIF-2α inhibitors represents a significant advancement in cancer therapy. His contributions to medical research continue to pave the way for improved treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile